semaglutide patent protection New Delhi, March 20, 2026 – The primary protecting semaglutide, the powerhouse ingredient in Novo Nordisk's globally renowned Ozempic and Wegovy, officially expired in India on Friday, March 20, 2026. This India's generic semaglutide surge |

For fiber, the general recommendation is 25 grams per day for women and 38 grams for men

A proof-of-concept analysis from the ongoing RESTORE clinical trial, conducted by researchers at the University of Colorado Anschutz Medical Campus, examined the impact of injectable semaglutide among participants aged 12 to 35 years with PCOS and obesity

Retatrutide: not yet available through standard channels Retatrutide is not FDA-approved

The common side effects and safety considerations for Semaglutide are as follows: Gastrointestinal symptoms are the most frequently reported and include nausea, vomiting, diarrhea, and constipation

Dehydration and electrolyte imbalances can also contribute, making hydration and balanced nutrition essential during treatment